- On May 28, 2025, the U.S. Food and Drug Administration (FDA) issued a “no questions” letter to Wildtype, Inc. in response to the California-based company’s pre-market evaluation filings for their
salmon
FDA Appeals Order Rejecting GE Salmon Approval
Posted on
- The FDA is appealing a November 5, 2020 decision by the U.S. District Court for the Northern District of California which ordered the Agency to reconsider its 2015 approval of
…
Continue Reading FDA Appeals Order Rejecting GE Salmon Approval